StockWatch
·

UCO BANK Q1 FY27 Results

UCOBANKQ1 FY27 Results
Filing
Result:Very Good· Market: Down#One-off hit#Margin expansion#Base effect#Broad based

Outlook: Optimistic · Guidance: Maintained

MetricValue ( Cr)Q4 FY26Q1 FY26
Revenue7.0K5.1%8.7%
Total Income8.7K17.9%16.8%
Expenditure5.9K1.4%0.0%
PBT2.6K106.5%172.1%
Net Profit656.3318.1%8.1%
OPM40.16%16.52pp15.89pp
NPM7.56%3.32pp0.61pp
EPS0.5218.8%8.3%
View full financials

Core banking metrics are a clear standout — NII +17% YoY, NIM up 9bps to 3.05%, GNPA/NNPA sharply better (2.63%→2.08% / 0.45%→0.25%) and provisions down ~62%, with reported PAT growth badly understated by a one-off DTA-remeasurement tax charge (adjusted PAT +212%).

UCO BANK · Q1 FY-2027 · THE VERDICT

Credit beats guidance, but revenue can't keep pace — margins under pressure

UCO's credit growth of 21% crushed its own 12–14% guidance. Yet revenue grew just 8.7%. That gap — advances racing ahead of income — is the quarter's defining risk. Layer on non-recurring items (₹800 crore in TWO recoveries, a ₹1,237 crore DTA charge) and the real earnings story becomes harder to defend.

02 Aug 2026 · 6 min read
Revenue growth

8.7%

YoY; lags credit by 12pp

Credit growth

21.18%

YoY; beat 12–14% guidance

Operating profit growth

79.8%

incl. ₹800 Cr non-recurring

Net profit growth

8.0%

YoY; suppressed by ₹1,237 Cr DTA

The earnings headline reads strong — credit outpaced guidance by a wide margin, deposits grew 11.3%, and net profit rose 8%. Yet the gap between 21% credit growth and 8.7% revenue growth is the real story. When your advances book races ahead of your income, either yields are compressing or your product mix is shifting lower — neither is a bullish signal. Add the non-recurring items — ₹800 crore in non-recurring TWO recoveries that inflated operating profit, and a ₹1,237 crore DTA charge from the tax regime shift that suppressed net profit — and the question becomes: what is the underlying earnings run-rate here?

Reconciling the reported numbers

₹ Crore
01,049.072,098.133,147.22,810Reported OP800Non-recurring TWO2,010Normalized OP
Operating profit surged 79.8% YoY to ₹2,810 Cr. Removing the ₹800 Cr non-recurring TWO recovery, normalized operating profit is ₹2,010 Cr — a much lower growth rate on the truly core business.

The core profit drivers were genuine: NII grew 16.85% and fee-based income jumped 35%, anchored by ₹2,000 crore in PSLC (Priority Sector Lending Certificate) sales that earned ₹55 crore in commission. But the total ₹1,018 crore TWO (Technical Write-Off) recovery — of which ₹800 crore is non-recurring — masked what would otherwise be a more pedestrian operating profit growth trajectory. In net profit, the impact was starker: a one-time ₹1,237 crore DTA (Deferred Tax Asset) charge from the mandatory shift to the new 25% corporate tax regime suppressed reported PAT to ₹656 crore. The regular tax provision for the quarter was ~₹625 crore, signalling a normalized tax load that will persist in future quarters and pressure PAT expansion.

What management claimed vs. what held up

Management's key claims on the call, graded against the reported result

Excellent business growth; advances 21.18%, deposits 11.28%

Actual

Both true. Revenue grew 8.7% YoY, lagging credit significantly.

Verdict

Supported on growth, but revenue gap understates margin pressure.

Operating profit up 79.8% YoY

Actual

Includes ₹1,018 Cr TWO recovery (₹800 Cr non-recurring); core growth much lower.

Verdict

Overstated; normalized OP growth is single-digit to low teens.

Net profit growth 8% reflects profitability improvement

Actual

Depressed by ₹1,237 Cr one-time DTA charge; regular tax provision ~₹625 Cr signals structural tax burden.

Verdict

Supported, but QoQ PAT decline (-18.1%) contradicts 'improvement' narrative.

Surpassed most guidance; credit 21% vs 12–14% target

Actual

Correct. But guidance NOT raised; MD called it conservative, said will review after Q2.

Verdict

Supported; guidance conservatism signals no acceleration priced in.

NIM maintained at 2.8–2.9% guidance; delivered 3.05%

Actual

NIM 3.05%, above guidance. Cost of funds 4.36% (down YoY), stable.

Verdict

Supported. But gap between NIM and revenue growth suggests yield compression ahead.

Asset quality improved; GNPA 2.08%, NNPA 0.25%

Actual

GNPA -55 bps YoY, NNPA -20 bps YoY, PCR 97.85%. All guidance targets met.

Verdict

Supported; best bright spot in the quarter.

What changed on this call

Three shifts materialized: First, credit growth delivery outpaced guidance by a wide margin. Announced 21.18% actual vs. 12–14% target, driven by 25.27% growth in the RAM (Retail & Agricultural & MSME) segment. RAM now represents 64.5% of advances — management's target is 62–65%, locked in. Second, NIM exceeded expectation at 3.05% vs. 2.8–2.9% guidance, sustained by stable cost of funds at 4.36% (down YoY after the repricing cycle). Third, and most concerning, revenue growth decoupled from credit growth. Revenue +8.7% YoY stands in sharp contrast to credit +21% — a 12-percentage-point gap that cannot be sustained. This was not flagged as a strategic shift; analysts pressed on it, but management didn't quantify or explain the product-mix or yield compression driving it.

The sequential deterioration

A troubling detail: PAT fell 18.1% quarter-on-quarter (from implied ₹801 Cr in Q4 FY26 to ₹656 Cr in Q1 FY27), despite revenue growing 5.1% QoQ. This is a red flag. When profit declines while revenue rises, either provisions, tax, or opex are spiking. Likely culprits: the DTA charge (a one-time tax write-down, limited to this quarter), provision build, or cost-to-income normalization. Management flagged that cost-to-income at 37.49% this quarter will normalize to ~50% by year-end — a 13-point drag. This QoQ deterioration explains the market's own verdict: the day-1 sell-off of -2.07% on the result has not recovered by day-5.

Market positioning & price action

The stock fell 2.07% on day 1 post-result and held losses — recovering only 0.41% by day 3 and fading further to -0.15% by day 5. This is the market's own verdict: the beat on credit growth did not excite, the margin lag raised concern, and the profit dependency on non-recurring items was seen through. Trading at ₹26.17, the stock is down 23.48% from its all-time high, below all three key moving averages (SMA20 ₹26.33, SMA50 ₹26.22, SMA200 ₹27.91). RSI at 46.5 (neutral, no oversold signal). Volume is normal. The ownership structure remains heavily promoter-locked (90.95%), with FII near zero (0.08%) and DII minimal (4.40%) — institutional money is not rotating into this print. The drawdown, combined with weak post-result momentum, signals the market sees structural headwinds.

The bull-bear ledger
  • Credit growth 21% vs 12–14% guidance; beat by wide margin

  • Deposit growth 11.28%, CASA +12.34%, strong franchise

  • Asset quality improved; NNPA 0.25% (best-in-PSU band), PCR 97.85%

  • NIM 3.05% above guidance; cost of funds stable at 4.36%

  • Revenue grows only 8.7% despite 21% credit growth — margin compression evident

  • Operating profit +79.8% inflated by ₹800 Cr non-recurring TWO; core growth much lower

  • PAT -18.1% QoQ despite +5.1% revenue growth; deterioration red flag

  • Cost-to-income normalizes from 37% to ~50%; efficiency gains temporary

  • Guidance maintained despite beats; signals no acceleration priced in

  • DTA charge one-time, but normalized tax burden remains elevated

Risks, ranked by holder concern

The risks that should concern a shareholder, in order of severity

Margin compression: revenue growth lags credit growth by 12pp

High

A 21% credit growth yielding only 8.7% revenue growth is not sustainable. Either yields are collapsing or the product mix is shifting lower. If this persists, NIM will erode and ROA will stagnate.

Sequential profit deterioration despite revenue growth

High

PAT fell 18.1% QoQ even as revenue rose 5.1% QoQ. This is a profitability cliff, not a one-quarter blip. If the trend continues into Q2, full-year guidance becomes at risk.

Operating profit non-recurring dependency

High

Operating profit +79.8% is driven largely by ₹800 Cr non-recurring TWO recovery. Strip it out and normalized OP growth is single-digit. Future quarters without similar recoveries will show weaker profit expansion.

Cost-to-income normalization from 37% to ~50%

Medium

A 13-percentage-point rise in cost-to-income is a major headwind. It will offset operational leverage from volume growth. The 37% this quarter was artificially low.

Revenue-credit growth gap unexplained

Medium

Analysts pressed on why revenue is growing so slowly despite 21% credit growth. The answer was vague. Until this is quantified, the bull case on profitability growth remains questionable.

ECLGS/MSME geopolitical stress

Medium

₹2,150 Cr sanctioned, ₹1,700 Cr disbursed under ECLGS 5.0. MSME lending is growing 18.79%, but stress could spike if external shocks escalate. Slippage 0.63% is controlled for now, but early-stage exposure.

Normalized tax burden elevated post-regime shift

Low

The ₹1,237 Cr DTA charge is one-time, but signals higher normalized tax provision (~₹625 Cr per quarter) going forward. This will pressure PAT growth unless pre-tax profit expands significantly.

What to watch next — the catalysts & turning points
  • 1 · Q2 FY27 guidance review (MD flagged after-Q2 assessment)

    If credit remains at 21% and revenue crawls at 8–10%, will guidance be raised on credit or revised down on revenue? The conservatism of the current 12–14% target will be tested. This is the first signal of whether margin lag is structural.

  • 2 · Cost-to-income trend (H1 vs. H2 FY27)

    If cost-to-income stays below 40% in Q2, the efficiency narrative holds. If it spikes to 45%+, the QoQ deterioration trend continues. This single metric will likely determine the full-year PAT trajectory.

  • 3 · GIFT City branch opening & international lending ramp

    International expansion is a revenue diversifier for PSU banks. A meaningful contribution from GIFT City would ease domestic revenue-growth pressure.

  • 4 · ECL transition (April 2027) — 60% provisioned, 40% to follow over 4–5 quarters

    The bank has accrued 60% of the ECL buffer. The remaining 40% will be recognized over 4–5 quarters, creating a provision drag that will suppress PAT into FY28. This is a headwind, not a surprise, but it's the invisible hand depressing earnings.

The honest read

UCO Bank is executing well on the volume levers — credit, deposits, CASA, asset quality. But volume growth is not translating to profitable growth. The 21% credit growth with 8.7% revenue growth is a red flag that will dog the stock until management either explains the gap or addresses it. The sequential PAT decline of 18.1% despite revenue growth is not a one-off; it signals that costs, provisions, and tax are structurally higher, offsetting volume gains. Operating profit inflated by non-recurring TWO recovery, net profit suppressed by one-time DTA charge — these are the tells that the underlying run-rate is lower than the headline suggests.

This is a steady, well-managed franchise with improving asset quality and a resilient deposit base. But this quarter reveals the limits of PSU scale in a competitive market. Growth is there; profitability is not accelerating in tandem. The market has priced this in (down 23.48% from ATH, flat post-result). The case for a step-change in returns hinges on one thing: can revenue growth catch up to credit growth? Until it does, the stock is a hold for those already in, but not compelling for new money.

The number to track from here is not credit or deposit growth — it's revenue growth. If Q2 shows revenue accelerating toward 12%+ and cost-to-income holding below 40%, the narrative shifts. If revenue stays in the 8–10% band and cost-to-income normalizes to 45%+, the Q1 margin-compression thesis wins. Management has signalled a Q2 review of guidance; that will be the moment of truth.

Informational and educational content only. Not investment advice.